Adults 40–75 who have COPD and experienced a flare-up in the past year may qualify for a study evaluating an investigational treatment.
COPD Flare-Up Prevention Study
Age Range:
40 to 75
Gender:
Male and Female
Location:
West Chester, Pennsylvania
About the Study
COPD flare-ups can be stressful and may make breathing even harder. Many people still experience flare-ups even while using their daily inhalers.
This research study is looking at an investigational injectable medication. The purpose is to learn whether targeting a specific type of inflammation found in some people with COPD may help reduce future flare-ups.
Participants will continue using their regular COPD inhalers throughout the study.
Qualifications
You may be able to join if you:
- Are 40 to 75 years old
- Have COPD diagnosed at least one year ago
- Had 1 COPD flare-up in the past year that required steroid treatment
- Are a current or former smoker with 10+ pack-years
- Are using dual or triple inhaler therapy (such as ICS/LABA, LABA/LAMA, or ICS/LABA/LAMA)
- Have Type 2 inflammation, shown by higher eosinophils (can be tested during screening)
FEATURED STUDIES
Weight Loss Research Study
Adults with overweight or obesity who do not have type 2 diabetes may qualify for a clinical research study evaluating
Heart Disease & Inflammation Study
Adults 18 years of age and older with elevated inflammation levels and heart disease or certain health conditions that increase
Heart Failure Prevention Study
Researchers are evaluating an investigational treatment for adults who have type 2 diabetes and cardiovascular disease and may be at
Weight & Wellness Research Study Interest
Researchers are evaluating an investigational oral treatment for adults who are overweight and may be at risk of developing certain
Flu Prevention Study – Higher-Risk Individuals
Researchers are evaluating an investigational medication that may help prevent the flu in people who are at higher risk of
General Anxiety Disorder Study
Individuals with generalized anxiety disorder (GAD) who experience ongoing worry, stress, or difficulty managing anxiety symptoms may qualify for a